Cargando…
The clinical significance of ultra-high D-dimer levels
OBJECTIVE: Plasma D-dimer levels >5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the Society for Vascular Surgery. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220196/ https://www.ncbi.nlm.nih.gov/pubmed/34171532 http://dx.doi.org/10.1016/j.jvsv.2021.06.011 |
_version_ | 1783711096926896128 |
---|---|
author | Schafer, Kristin Goldschmidt, Eric Oostra, Drew Fish, John Russell, Todd Lurie, Fedor |
author_facet | Schafer, Kristin Goldschmidt, Eric Oostra, Drew Fish, John Russell, Todd Lurie, Fedor |
author_sort | Schafer, Kristin |
collection | PubMed |
description | OBJECTIVE: Plasma D-dimer levels >5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels >5000 ng/mL and investigated the clinical significance of this finding before the onset of the COVID-19 pandemic. METHODS: Inpatient records for a 4-year period were screened for laboratory results of plasma D-dimer levels >5000 ng/mL. The patient data were reviewed for the clinical identifiers commonly associated with elevated plasma D-dimer levels, including VTE, cancer, sepsis, pneumonia, other infection, bleeding, and trauma. The patients were then categorized into groups stratified by the plasma D-dimer level to allow for comparisons between the various clinical diagnoses. RESULTS: A total of 671 patients were included in the present study. VTE was the most common diagnosis for patients with a plasma D-dimer level >5000 ng/mL, followed by cancer and pneumonia. Multiple clinical diagnoses were present in 61% of the patients. No clear cause for the ultra-high plasma D-dimer level could be identified in 11.3% of the patients. Among the patients lacking a clinical diagnosis at discharge, mortality was 24% in the 5000- to 10,000-ng/mL group, 28.6% in the 10,000- to 15,000-ng/mL group, and 75% in the >15,000-ng/mL group. CONCLUSIONS: VTE, cancer, and pneumonia were frequently present when ultra-high plasma D-dimer levels were encountered, and mortality was high when the levels were >15,000 ng/mL. The results from our study from a pre–COVID-19 patient population suggest that ultra-high plasma D-dimer levels indicate the presence of severe underlying disease. This should be considered when using the plasma D-dimer level as a screening tool or prognostic indicator for COVID-19 infection. |
format | Online Article Text |
id | pubmed-8220196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | by the Society for Vascular Surgery. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82201962021-06-23 The clinical significance of ultra-high D-dimer levels Schafer, Kristin Goldschmidt, Eric Oostra, Drew Fish, John Russell, Todd Lurie, Fedor J Vasc Surg Venous Lymphat Disord Venous disease and COVID-19 OBJECTIVE: Plasma D-dimer levels >5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels >5000 ng/mL and investigated the clinical significance of this finding before the onset of the COVID-19 pandemic. METHODS: Inpatient records for a 4-year period were screened for laboratory results of plasma D-dimer levels >5000 ng/mL. The patient data were reviewed for the clinical identifiers commonly associated with elevated plasma D-dimer levels, including VTE, cancer, sepsis, pneumonia, other infection, bleeding, and trauma. The patients were then categorized into groups stratified by the plasma D-dimer level to allow for comparisons between the various clinical diagnoses. RESULTS: A total of 671 patients were included in the present study. VTE was the most common diagnosis for patients with a plasma D-dimer level >5000 ng/mL, followed by cancer and pneumonia. Multiple clinical diagnoses were present in 61% of the patients. No clear cause for the ultra-high plasma D-dimer level could be identified in 11.3% of the patients. Among the patients lacking a clinical diagnosis at discharge, mortality was 24% in the 5000- to 10,000-ng/mL group, 28.6% in the 10,000- to 15,000-ng/mL group, and 75% in the >15,000-ng/mL group. CONCLUSIONS: VTE, cancer, and pneumonia were frequently present when ultra-high plasma D-dimer levels were encountered, and mortality was high when the levels were >15,000 ng/mL. The results from our study from a pre–COVID-19 patient population suggest that ultra-high plasma D-dimer levels indicate the presence of severe underlying disease. This should be considered when using the plasma D-dimer level as a screening tool or prognostic indicator for COVID-19 infection. by the Society for Vascular Surgery. Published by Elsevier Inc. 2022-01 2021-06-23 /pmc/articles/PMC8220196/ /pubmed/34171532 http://dx.doi.org/10.1016/j.jvsv.2021.06.011 Text en © 2021 by the Society for Vascular Surgery. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Venous disease and COVID-19 Schafer, Kristin Goldschmidt, Eric Oostra, Drew Fish, John Russell, Todd Lurie, Fedor The clinical significance of ultra-high D-dimer levels |
title | The clinical significance of ultra-high D-dimer levels |
title_full | The clinical significance of ultra-high D-dimer levels |
title_fullStr | The clinical significance of ultra-high D-dimer levels |
title_full_unstemmed | The clinical significance of ultra-high D-dimer levels |
title_short | The clinical significance of ultra-high D-dimer levels |
title_sort | clinical significance of ultra-high d-dimer levels |
topic | Venous disease and COVID-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220196/ https://www.ncbi.nlm.nih.gov/pubmed/34171532 http://dx.doi.org/10.1016/j.jvsv.2021.06.011 |
work_keys_str_mv | AT schaferkristin theclinicalsignificanceofultrahighddimerlevels AT goldschmidteric theclinicalsignificanceofultrahighddimerlevels AT oostradrew theclinicalsignificanceofultrahighddimerlevels AT fishjohn theclinicalsignificanceofultrahighddimerlevels AT russelltodd theclinicalsignificanceofultrahighddimerlevels AT luriefedor theclinicalsignificanceofultrahighddimerlevels AT schaferkristin clinicalsignificanceofultrahighddimerlevels AT goldschmidteric clinicalsignificanceofultrahighddimerlevels AT oostradrew clinicalsignificanceofultrahighddimerlevels AT fishjohn clinicalsignificanceofultrahighddimerlevels AT russelltodd clinicalsignificanceofultrahighddimerlevels AT luriefedor clinicalsignificanceofultrahighddimerlevels |